Associated Papers
High-throughput screens identify genotype-specific therapeutics for channelopathies.
Egly CL et al.
Jci Insight, 2025
41026531 (PubMed )
Supplement: jciinsight-10-191697-s190.xlsx › Figure_6B
Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3.
Gardner A et al.
Molecular Pharmacology, 2017
Hydrophobic interactions between the voltage sensor and pore mediate inactivation in Kv11.1 channels.
Perry MD et al.
The Journal of General Physiology, 2013
23980196 (PubMed )
Supplement: supp_jgp.201310975_JGP_201310975_sm.pdf
Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
Durdagi S et al.
The Journal of Pharmacology and Experimental Therapeutics, 2012
Select a paper to view details